Jane Street Group, LLC Regenxbio Inc. Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

A detailed history of Jane Street Group, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 94,970 shares of RGNX stock, worth $887,969. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94,970
Holding current value
$887,969
% of portfolio
0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$11.51 - $21.53 $1.09 Million - $2.04 Million
94,970 New
94,970 $1.11 Million
Q4 2023

Feb 14, 2024
BUY
$12.89 - $20.82 $185,719 - $299,974
14,408 Added 48.16%
44,326 $795,000
Q3 2023

Nov 14, 2023
SELL
$16.46 - $19.99 $13,233 - $16,071
-804 Reduced 2.62%
29,918 $492,000
Q2 2023

Aug 14, 2023
SELL
$17.23 - $21.71 $89,837 - $113,195
-5,214 Reduced 14.51%
30,722 $614,000
Q1 2023

May 15, 2023
BUY
$18.08 - $24.55 $50,352 - $68,371
2,785 Added 8.4%
35,936 $679,000
Q4 2022

Feb 14, 2023
BUY
$20.4 - $24.73 $436,682 - $529,370
21,406 Added 182.26%
33,151 $751,000
Q3 2022

Nov 14, 2022
BUY
$22.29 - $35.04 $261,796 - $411,544
11,745 New
11,745 $310,000
Q3 2022

Nov 14, 2022
BUY
$22.29 - $35.04 $261,796 - $411,544
11,745 New
11,745 $310,000
Q2 2022

Aug 16, 2022
SELL
$19.35 - $35.04 $288,315 - $522,096
-14,900 Closed
0 $0
Q1 2022

May 17, 2022
BUY
$24.62 - $34.31 $5,071 - $7,067
206 Added 1.4%
14,900 $495,000
Q4 2021

Feb 15, 2022
BUY
$30.19 - $40.28 $224,764 - $299,884
7,445 Added 102.7%
14,694 $480,000
Q3 2021

Nov 16, 2021
SELL
$29.09 - $45.68 $17,744 - $27,864
-610 Reduced 7.76%
7,249 $304,000
Q2 2021

Aug 16, 2021
SELL
$32.46 - $40.48 $150,744 - $187,989
-4,644 Reduced 37.14%
7,859 $306,000
Q1 2021

May 18, 2021
SELL
$33.61 - $49.95 $2.48 Million - $3.69 Million
-73,792 Reduced 85.51%
12,503 $426,000
Q4 2020

Feb 17, 2021
BUY
$26.52 - $49.35 $1.77 Million - $3.3 Million
66,816 Added 343.02%
86,295 $3.92 Million
Q3 2020

Nov 17, 2020
BUY
$27.01 - $40.26 $526,127 - $784,224
19,479 New
19,479 $536,000
Q4 2019

Feb 14, 2020
SELL
$34.54 - $44.87 $218,292 - $283,578
-6,320 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$31.84 - $50.88 $201,228 - $321,561
6,320 New
6,320 $225,000
Q4 2018

Feb 15, 2019
SELL
$39.11 - $75.15 $433,377 - $832,737
-11,081 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$65.0 - $82.15 $720,265 - $910,304
11,081 New
11,081 $837,000
Q4 2017

Feb 15, 2018
SELL
$26.0 - $34.6 $375,570 - $499,797
-14,445 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$18.0 - $32.95 $260,010 - $475,962
14,445
14,445 $476,000

Others Institutions Holding RGNX

# of Institutions
193
Shares Held
43.5M
Call Options Held
58.9K
Put Options Held
58.4K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $404M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email